Markus Möhler

1.2k total citations
35 papers, 636 citations indexed

About

Markus Möhler is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Markus Möhler has authored 35 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 11 papers in Surgery. Recurrent topics in Markus Möhler's work include Gastric Cancer Management and Outcomes (22 papers), Colorectal Cancer Treatments and Studies (9 papers) and Metastasis and carcinoma case studies (8 papers). Markus Möhler is often cited by papers focused on Gastric Cancer Management and Outcomes (22 papers), Colorectal Cancer Treatments and Studies (9 papers) and Metastasis and carcinoma case studies (8 papers). Markus Möhler collaborates with scholars based in Germany, Switzerland and Austria. Markus Möhler's co-authors include T Junginger, Heinz Schmidberger, Daniel Wachtlin, Thomas Borschitz, Volker Heinemann, Peter Thuss‐Patience, Antonia Dimitrakopoulou‐Strauss, Sylvie Lorenzen, Ludwig G. Strauss and Franz Oberdorfer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Markus Möhler

28 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Möhler Germany 15 428 251 250 99 66 35 636
Takashi Ichimura Japan 12 361 0.8× 143 0.6× 274 1.1× 58 0.6× 87 1.3× 52 579
Wataru Takayama Japan 13 265 0.6× 218 0.9× 170 0.7× 98 1.0× 19 0.3× 51 513
Teruyuki SAKAGUCHI Japan 7 344 0.8× 197 0.8× 329 1.3× 69 0.7× 94 1.4× 13 651
André L. Montagnini Brazil 13 360 0.8× 282 1.1× 320 1.3× 55 0.6× 51 0.8× 40 671
Matthew Chau Hsien Ng Singapore 14 199 0.5× 132 0.5× 170 0.7× 27 0.3× 77 1.2× 43 455
Masahiro Serikawa Japan 12 424 1.0× 400 1.6× 210 0.8× 59 0.6× 20 0.3× 61 620
Gontran Verset Belgium 13 348 0.8× 281 1.1× 164 0.7× 30 0.3× 82 1.2× 36 603
W. Y. Lee China 10 343 0.8× 397 1.6× 219 0.9× 28 0.3× 43 0.7× 11 678
Yasuyuki Kawamoto Japan 13 399 0.9× 222 0.9× 210 0.8× 21 0.2× 117 1.8× 68 530
A. Wein Germany 16 485 1.1× 309 1.2× 260 1.0× 19 0.2× 97 1.5× 43 777

Countries citing papers authored by Markus Möhler

Since Specialization
Citations

This map shows the geographic impact of Markus Möhler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Möhler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Möhler more than expected).

Fields of papers citing papers by Markus Möhler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Möhler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Möhler. The network helps show where Markus Möhler may publish in the future.

Co-authorship network of co-authors of Markus Möhler

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Möhler. A scholar is included among the top collaborators of Markus Möhler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Möhler. Markus Möhler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keller, Karsten, Volker H. Schmitt, Omar Hahad, et al.. (2025). Cardiovascular comorbidities predict mortality in acute pancreatitis. International Journal of Cardiology. 435. 133409–133409.
2.
Lordick, Florian, Salah‐Eddin Al‐Batran, Dirk Arnold, et al.. (2023). German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer. Gastric Cancer. 27(1). 6–18. 3 indexed citations
3.
Helali, Aya El, Charlene H. L. Wong, Wing‐Lok Chan, et al.. (2022). A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancer. Frontiers in Oncology. 12. 14 indexed citations
4.
Möhler, Markus. (2021). PMT-Gesetz: Wichtige Bestimmungen sind weder verfassungs- noch EMRK-konform. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Tannapfel, Andrea, Anke Reinacher‐Schick, Ulrich Hacker, et al.. (2019). Immunotherapy: New Options in Gastrointestinal Cancers?. Visceral Medicine. 35(1). 47–51.
7.
Lordick, Florian, Salah‐Eddin Al‐Batran, Manfred Dietel, et al.. (2017). HER2 testing in gastric cancer: results of a German expert meeting. Journal of Cancer Research and Clinical Oncology. 143(5). 835–841. 38 indexed citations
9.
Schmidtmann, Irene, Thomas Thomaidis, Peter R. Galle, et al.. (2016). Last line therapy with sorafenib in colorectal cancer: A retrospective analysis. World Journal of Gastroenterology. 22(23). 5400–5400. 7 indexed citations
10.
Mahlberg, Rolf, Sylvie Lorenzen, Peter Thuss‐Patience, et al.. (2016). New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin. Chemotherapy. 62(1). 62–70. 34 indexed citations
11.
Thomaidis, Thomas, Marcus A. Wörns, Peter R. Galle, Markus Möhler, & Jörn M. Schattenberg. (2014). Treatment of Malignant Ascites with a Second Cycle of Catumaxomab in Gastric Signet Cell Carcinoma - a Report of 2 Cases. Oncology Research and Treatment. 37(11). 674–677. 5 indexed citations
12.
Heinemann, Volker, Dominik Paul Modest, Ludwig Fischer von Weikersthal, et al.. (2014). Independent Radiological Evaluation of Objective Response Early Tumor Shrinkage, and Depth of Response in FIRE-3 (AIO KRK-0306). Annals of Oncology. 25. ii117–ii117. 20 indexed citations
14.
Meyer, H.-J., Arnulf H. Hölscher, Florian Lordick, et al.. (2011). Aktuelle S3-Leitlinie zur Chirurgie des Magenkarzinoms. Der Chirurg. 83(1). 31–37. 29 indexed citations
15.
Ebert, Matthias P., Christoph J. Auernhammer, K Caca, et al.. (2009). Gastrointestinale Onkologie – Therapieupdate 2008 / 2009. Zeitschrift für Gastroenterologie. 47(3). 296–306. 1 indexed citations
16.
Hofheinz, Ralf‐Dieter, Frederik Wenz, Sabine Mai, et al.. (2008). Oxaliplatin and Capecitabine-Based Chemoradiotherapy for Gastric Cancer—An Extended Phase I MARGIT and AIO Trial. International Journal of Radiation Oncology*Biology*Physics. 73(1). 142–147. 16 indexed citations
17.
Möhler, Markus, et al.. (2008). Hereditäre Lebererkrankungen: Neue molekulargenetische Aspekte. DMW - Deutsche Medizinische Wochenschrift. 123(15). 466–471.
18.
Möhler, Markus & Peter R. Galle. (2007). Aktuelle Diagnostik und Therapie des Magenkarzinoms. 3(1). 17–32. 1 indexed citations
19.
Möhler, Markus, et al.. (1997). Case Report: Primary Hepatic High-Grade Non-Hodgkin's Lymphoma and Chronic Hepatitis C Infection. Digestive Diseases and Sciences. 42(11). 2241–2245. 24 indexed citations
20.
Kleinschmidt, Jürgen A., et al.. (1995). Sequence elements of the adeno-associated virus rep gene required for suppressionof herpes-simplex-virus-induced DNA amplification. Virology. 206(1). 254–262. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026